Insider Transactions

David Farr, director at International Business Machines (IBM), recently bought 1,200 shares. The buy increased his stake by 17%, and came to total cost of $298,800. This marks the first insider buy since last November, when another company director bought 936 shares at a cost of just over $197,000, representing an initial stake. Going further back, there were two small insider sales from SVPs in 2024. This constitutes all insider activity over the past two years. Overall, IBM insiders own 0.4% of ...
Read More About This

Carles Hernandez, a director at PG&E Corp. (PCG), recently bought 3,142 shares. The buy increased his position by 10%, and came to a total cost of $49,989. Another company director also bought $50,000 on the same day, and two additional directors bought shares in the prior week. Going back further, company insiders were sellers of shares, including three sales from the company CEO. Overall, PG&E insiders own 2.7% of shares. The power and gas utility is down 4% over the past year, far ...
Read More About This

Franklin Myers, a director at HF Sinclair Corp (DINO), recently bought 5,000 shares. The buy increased his stake by 3%, and came to a total cost of $178,314. Myers was a repeat buyer throughout 2024, with buys in the $105,000 to $373,000 range. In the past few months, the company CEO and CFO have also been buyers of shares around the same price. The last insider sales occurred in early 2024. Overall, HF Sinclair insiders own 9.1% of shares. The oil and gas ...
Read More About This

Nancy Benacci, a director at Cincinnati Financial (CINF), recently bought 1,000 shares. The buy increased her stake by 15%, and came to a total cost of $136,160. This marks the first insider buy of 2025. Over the past two years, insiders were mostly buyers of shares, although one company director with over 1.1 million shares has been lightening his position. There have been no trades from company executives over the past two years. Overall, insiders at the property and casualty insurance company ...
Read More About This

Robert Eifler, President and CEO of Noble Corp (NE) recently bought 12,568 shares. The buy increased his position by 1%, and came to a total cost of $350,019. He was joined by the company CFO, who bought 8,000 shares for just over $223,250, and who increased his position by 3%. A company director also bought 8,992 shares, increasing his stake by 31%. Going further back, insiders have been slight sellers of shares at higher prices. Overall, Noble Corp insiders own 21.4% of ...
Read More About This

Christopher Boerner, CEO of Bristol Myers Squibb (BMY), recently bought 2,000 shares. The buy increased his stake by 2%, and came to a total cost of $110,096. The CEO was also a buyer in late 2023 on multiple occasions. The latest buy came a week after a company EVP bought 1,823 shares, paying $100,000 for doing so. Going further back, company insiders have been net buyers since late 2023, and sellers earlier in 2023 at much higher share prices. Overall, Bristol Myers ...
Read More About This

Ruth Porat, a director at Blackstone (BX), recently bought 376 shares. The buy increased her stake by 1%, and came to a total cost of $61,926. Porat is a quarterly buyer of shares, and last bought in November, picking up 217 shares at a cost of less than $37,000. Otherwise, the company’s general council sold off 9% of his holdings for $7.45 million. Going further back, there’s been a similar mix of buyers and sellers. Overall, Blackstone insiders own 1.2% of shares. The ...
Read More About This

Michael Mahoney, a director at CVS Health (CVS), recently bought 30,000 shares. The buy increased his position by a massive 190%, and came to a total cost of just over $2 million. Mahoney was a buyer of over 9,100 shares last May, for just over $500,000. Another director also picked up 1,000 shares around the same period. Going back further, insiders were equally buyers and sellers of shares at a price near where CVS shares trade today. Overall, CVS Health insiders own ...
Read More About This